SCHEMBL3635918

SCHEMBL3635918

Clc1ccc(CNc2nc(N3CCCCC3)c3ccccc3n2)c(Cl)c1.Fc1ccc(CNc2nc(N3CCCCC3)c3ccccc3n2)cc1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MRGPRX1 Q96LB2 1/20 0.59
MAOB P27338 2/20 0.46
APP P05067 1/20 0.44
HRH4 Q9H3N8 1/20 0.44
CTNNB1 P35222 2/20 0.43
TCF7L2 Q9NQB0 2/20 0.43
KDM4E B2RXH2 3/20 0.43
MAPK1 P28482 3/20 0.43
LMNA P02545 3/20 0.43
HPGD P15428 2/20 0.43
TSHR P16473 2/20 0.43
CCR4 P51679 1/20 0.42
NTRK1 P04629 3/20 0.41
ATM Q13315 2/20 0.41
L3MBTL1 Q9Y468 2/20 0.41
CTDSP1 Q9GZU7 1/20 0.41
ACP1 P24666 1/20 0.41
ABCB1 P08183 1/20 0.41
MEN1 O00255 2/20 0.41
MAPT P10636 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3640644 0.91 MRGPRX1 (0.63) MRGPRX1MAOBKDM4EMAPK1LMNA
Hydrochloric Acid SCHEMBL3645056 0.90 MRGPRX1 (0.62) MRGPRX1MAOBKDM4EMAPK1LMNA
SCHEMBL3637654 0.87 MRGPRX1 (0.61) MRGPRX1MAOBAPPCTNNB1TCF7L2
Hydrochloric Acid SCHEMBL3638859 0.86 MRGPRX1 (0.60) MRGPRX1MAOBAPPCTNNB1TCF7L2
SCHEMBL3636984 0.85 MRGPRX1 (0.79) MRGPRX1MAOBAPPKDM4EMAPK1
Hydrochloric Acid SCHEMBL3643496 0.84 MRGPRX1 (0.77) MRGPRX1MAOBAPPKDM4EMAPK1
SCHEMBL1090783 0.79 MRGPRX1 (0.65) MRGPRX1MAOBAPPKDM4EMAPK1
SCHEMBL1092285 0.79 MRGPRX1 (0.65) MRGPRX1MAOBAPPKDM4EMAPK1
SCHEMBL1090716 0.79 MRGPRX1 (0.65) MRGPRX1MAOBAPPKDM4EMAPK1
SCHEMBL1090790 0.78 MRGPRX1 (0.66) MRGPRX1APPHRH4KDM4EMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2173346-A2 USE OF COMPOUNDS FOR PREPARING ANTI-TUBERCULOSIS AGENTS Summit Corporation Plc (GB) 2010-04-14 EP disclosed
WO-2009001060-A2 USE OF COMPOUNDS FOR PREPARING ANTI-TUBERCULOSIS AGENTS SUMMIT CORPORATION PLC (GB) 2008-12-31 WO disclosed